Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, (Q50905262)
Jump to navigation
Jump to search
scientific article published on 13 June 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, |
scientific article published on 13 June 2013 |
Statements
1 reference
Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, (English)
1 reference
Christie M Ballantyne
1 reference
Michael H Davidson
1 reference
Diane E Macdougall
1 reference
Harold E Bays
1 reference
Lorenzo A Dicarlo
1 reference
Noah L Rosenberg
1 reference
Janice Margulies
1 reference
Roger S Newton
1 reference
13 June 2013
1 reference
62
1 reference
1154-1162
1 reference
13
1 reference
Identifiers
1 reference